BioFire
Top Five Articles on 360Dx Last Week: Siemens Healthineers Layoffs and Atellica Focus; and More
Last week, readers were most interested in a story about changes at Siemens Healthineers as it plans to shut down some of its legacy instruments.
BioMérieux Gets CLIA Waiver for BioFire SpotFire Respiratory Panel Mini
The CLIA waiver now allows the SpotFire system and two existing panels to be used by non-lab professionals at the point of care, the firm said.
BioMérieux Q1 Revenues Rise 8 Percent
The firm saw revenue growth across almost all business divisions, with a 32 percent jump in BioFire portfolio sales.
Multicenter Study Finds BioFire Joint Infection Panel Shows High Accuracy Despite Limitations
Premium
The assay received de novo authorization from the US Food and Drug Administration and CE-IVD marking last year.
BioMérieux's BioFire Defense Wins BARDA Contract to Further Develop Rapid AST System
The contract supports expanding the menu of the Specific Reveal antimicrobial susceptibility testing platform to include additional sample types and targets.
Feb 16, 2023
Jan 28, 2022
Sep 1, 2021
BioMérieux H1 Revenues Rise 7 Percent
Oct 22, 2020